HPV & Screening

ENGAGe is one of the of the stakeholders in the European RISCC project

RISCC stands for “RIsk-based Screening for Cervical Cancer” and has received funding from the European Union’s Horizon2020 Framework Programme for Research and Innovation.


Screening in the Nonavalent Vaccine Era: What Do We Know and What Do We Need to Know?

World expert, Joakim Dillner, Karolinska Institute and Karolinska Hospital, Sweden shares the latest insights and take-home messages on HPV and Screening at the ENGAGe Patient Seminar in Antalya, during the ESGO 2016 State of the Art Conference.

Watch the video on the ENGAGe Channel!

You May Also Like


Patient Advocacy Seminars

March 7-9, 2024 in Barcelona, Spain

Read More


Raise Awareness

Cancer Fact Sheets

Read More


ENGAGe Calendar of Events

Designed For you! 

Read More

Hungary 1

Patient Stories


Read More